维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

18篇 您的检索式：作者名="Letter MA"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	Critical illness polyneuropathy and myopathy (CIPNM): evidence for local immune activation by cytokine-expression in the muscle tissue显示文摘	De Letter MA van Doom PA Savelkoul HF	2000	J Neuroimmunol2000，106，：	1
	2	Cell generated nitric oxide inactivates rat hepatocyte mitochondria in vitro but reacts with hemoglobin in vivo显示文摘	Fisch C Robin MA Letter P	1996	Gastroenterology1996，110，1：	1
	3	Critical illness polyneuropathy and myopathy (CIPNM):evidence for local immune activation by cytokine-expression in the muscle tissue显示文摘	De Letter MA van Doorn PA Savelkoul HF	2000	J Neuroimmunol2000，106，12：	1
	4	Risk factors for the development of polyneuropathy and myopathy in critically ill patients显示文摘	de Letter MA Schmitz PI Visser LH	2001	Crit Care Med2001，29，12：	1
	5	Risk factors for the development of polyneuropathy and myopathyin critically ill patients显示文摘	De Letter MA Schmitz PI Visser LH	2001	Crit Care Med2001，29，12：	1
	6	Risk factors for the development ofpolyneuropathy and myopathy in critically ill patients 显示文摘	de Letter MA Schmitz PIM Visser LH	2001	Crit Care Med2001，29，12：	1
	7	Risk factors for the de- velopment of polyneuropathy and myopathy in critically ill pa- tients显示文摘	Letter MA Schmitz PI Visser LH	2001	Crit Care Med2001，29，12：	1
	8	Risk factors for the develop-ment of polyneuropathy and myopathy in critically ill patients显示文摘	Letter MA Schmitz PI Visser LH	2001	CritCare Med2001，29，12：	1
	9	Risk facors t'or he de- velopment of polyneuropathy and myopathy in critically ill pa- tients显示文摘	Letter MA Schmi*z PI Visser Lbl et ag	2001	Crit Care Med2001，29，12：	1
	10	Risk factors for thedevelopment of polyneuropathy and myopathy in critically ill pa-tients显示文摘	de Letter MA Schmitz PI Visser LH	2001	Crit Care Med2001，29，：	1
	11	Risk factors for the devel- opment of polyrteuropathy and myopathy in criticall ill patients 显示文摘	De Letter MA Schmitz PI Visser LH	2001	Crit Care Med2001，29，12：	1
	12	Risk factors for the development of polyneuropathy and myopathy in critically ill patients显示文摘	Letter MA Schmitz PI Visser LH	2001	Crit Care Med2001，29，12：	1
	13	Risk factors for the development of polyneuropathy and myopathy in critically ill patients显示文摘	Letter MA Schmitz PI Visser LH	2001	Critical Care Medicine2001，29，12：	1
	14	Critical illness polyneuropathy and myopathy (CIPNM):evidence for local immune activation by cytokine-expression in the muscle tissue显示文摘	De Letter MA van Doom PA Savelkoul HF	2000	J Neuroimmunol2000，106，12：	1
	15	Critical illness polyneuropathy and myopathy(CIPNM):evidence for local immune activation by cytokine-expression in the muscle tissue显示文摘	De Letter MA Van Doorn PA Savelkoul HF	2000	J Neuroimmunol2000，106，12：	1
	16	Risk factors for the development of polyneuropathy and myopathy in critically ill patients显示文摘	de Letter MA Schmitz PI Visser LH	2001	Crit Care Med2001，29，12：	1
	17	Cell generated nitric oxide inactivates rat hepatocyte mitotrochondria in vitro but reacts with hemoglobin in vivo显示文摘	Fisch C Robin MA Letter P	1996	Gastroenterology1996，110，1：	1
	18	Risk factors for the development of polyneuropathy and myopathy in critically ill patients显示文摘	De Letter MA Schmitz PI Visser LH	2001	Crit Care Med2001，29，12：	1

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费